Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Icagen, Inc. (NASDAQ: ICGN), Pfizer, Inc. (NYSE: PFE), Pain Therapeutics, Inc. (NASDAQ: PTIE), and Zalicus, Inc. (NASDAQ: ZLCS).
Icagen, Inc. (NASDAQ: ICGN) is up more than 150% premarket to $6.10, relative to a 52-week range of $0.93-$4.46. It is rumored that the company may be acquired by Pfizer, Inc. (NYSE: PFE).
Pain Therapeutics, Inc. (NASDAQ: PTIE) is down nearly 25% premarket to $4.00, well below a 52-week range of $4.91-$10.45. Last week, the FDA denied approval of the company’s pain medication.
Zalicus, Inc. (NASDAQ: ZLCS) is up 5% before market open to $2.54, relative to a 52-week range of $1.01-$3.21.
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
